PDF herunterladen
Synlett 2002(12): 2080-2082
DOI: 10.1055/s-2002-35562
LETTER
© Georg Thieme Verlag Stuttgart · New York

Efficient Synthesis of a New Potential Chelating Agent for Radioimmunotherapy

Sébastien G. Gouina,b, Jean-François Gestinb,c, Patricia Remaudb, Alain Faivre-Chauvetb, Jean Claude Meslina, David Deniaud*a
a Laboratoire de Synthèse Organique, UMR CNRS 6513, Faculté des Sciences et des Techniques, 2 rue de la Houssinière, BP 92208, 44072 Nantes Cedex, France
b INSERM U463, Chimie des bioconjugués, 9 quai Moncousu, 44093 Nantes Cedex, France
Fax: +33(251)125402; e-Mail: david.deniaud@chimie.univ-nantes.fr;
c CHELATEC SAS, Institut de Biologie, 9 quai Moncousu, 44093 Nantes Cedex, France
Weitere Informationen

Publikationsverlauf

Received 16 July 2002
Publikationsdatum:
20. November 2002 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The synthesis of a new rigid analogue of cyclohexyl-TTHA, an efficient lanthanide ligand, as well, as the first complexation trials are reported. This polyaminopolycarboxylic acid, Ph-DTHA 1, was obtained in five steps from phenylenediamine as starting product. The key intermediate was phenylenediethylenetetraamine 4, which after alkylation and hydrolysis gave the expected compound 1 with ten coordination centers.

Key words

ligands - polyaminopolycarboxylic acids - radioimmunotherapy - complexes - radionuclides

    References

  • 1 Chatal J.-F. Peltier P. Bardies M. Chetanneau A. Resche I. Mahe M. Charbonnel B. Med. Nuc. I. Met.  1993,  17:  81 
    Google Scholar
  • 2a Gouin SG. Gestin J.-F. Joly K. Loussouarn A. Reliquet A. Meslin J.-C. Deniaud D. Tetrahedron  2002,  58:  1131 
    CrossrefGoogle Scholar
  • 2b Ouadi A. Loussouarn A. Remaud P. Morandeau L. Apostolidis C. Musikas C. Faivre-Chauvet A. Gestin J.-F. Tetrahedron Lett.  2000,  41:  7207 
    CrossrefGoogle Scholar
  • 3a De Sousa AS. Croft GJB. Wagner CA. Michael JP. Hancock RD. Inorg. Chem.  1991,  30:  3525 
    CrossrefGoogle Scholar
  • 3b Hancock RD. Martell AE. Coord. Chem. Rev.  1994,  133:  39 
    CrossrefGoogle Scholar
  • 4 Fossheim R. Dugstad H. Dahl SG. J. Med. Chem.  1991,  34:  819 
    CrossrefGoogle Scholar
  • 5a Gouin SG. Gestin J.-F. Reliquet A. Meslin J.-C. Deniaud D. Tetrahedron Lett.  2002,  43:  3003 
    Google Scholar
  • 5b McMurry TJ. Pippin CG. Wu C. Deal KA. Brechbiel MW. Mirzadeh S. Gansow OA. J. Med. Chem.  1998,  41:  3546 
    Google Scholar
  • 5c Chong H.-S. Garmestani K. Bryant H. Brechbiel MW. J. Org. Chem.  2001,  66:  7745 
    Google Scholar
  • 5d Matthew AW. Rapoport H. J. Org. Chem.  1994,  59:  3616 
    Google Scholar
  • 5e Grote CW. Jin Kim D. Rapoport H. J. Org. Chem.  1995,  60:  6987 
    Google Scholar
  • 6 Mease RC, Srivastava SC, and Gestin J.-F. inventors; Patent WO  5089663. 
  • 7a Ishikura M. Mori M. Ikeda T. Terashima M. Ban Y. J. Org. Chem.  1982,  47:  2456 
    CrossrefGoogle Scholar
  • 7b Schepartz A. Breslow R. J. Am. Chem. Soc.  1987,  109:  1814 
    CrossrefGoogle Scholar
  • 7c Juaristi E. Rizo B. Natal V. Escalante J. Regala I. Tetrahedron: Asymmetry  1991,  2:  821 
    CrossrefGoogle Scholar
  • 8 Pascal R. Chauvey D. Sola R. Tetrahedron Lett.  1994,  35:  6291 
    CrossrefGoogle Scholar
  • 9 Guan Y. Green MA. Bergstrom DE. Synlett  1999,  4:  426 
    Artikel in Thieme ConnectGoogle Scholar
  • 10 Atherton E. Sheppard RC. The Peptides Academic Press  1987,  9:  11 
    Google Scholar
  • 11a Moreau P. Tinkl M. Tsukazaki M. Bury PS. Griffen EJ. Snieckus V. Maharajh RB. Kwork CS. Somayaji VV. Peng Z. Sykes TR. Noujaim AA. Synthesis  1997,  9:  1010 
    CrossrefGoogle Scholar
  • 11b Achmatowicz M. Jurczak J. Tetrahedron: Asymmetry  2001,  12:  487 
    CrossrefGoogle Scholar
  • 12 Spänig H, Dokner T, and Frank A. inventors; Patent DE  2057744. 
  • 13 Heppler A. Froidevaux S. Mäcke HR. Jermann E. Chem. Eur. J.  1999,  7:  1974 
    Google Scholar
  • 14a Brunet E. Alonso MT. Juanes O. Velasco O. Rodriguez-Ubis JC. Tetrahedron  2001,  57:  3105 
    CrossrefGoogle Scholar
  • 14b Rodriguez-Ubis JC. Alonso MT. Brunet E. Tetrahedron Lett.  1994,  35:  8461 
    CrossrefGoogle Scholar
15

Spectrum data of compound 1: IR (KBr): 3419, 2970, 1733, 1635, 1418, 1256 cm-1; 1H NMR (200 MHz, D2O): δ = 3.49 [4 H, m, 2 × NCH2CH 2N(CH2CO2H)2], 3.69 (4 H, m, 2 × NCH 2CH2N(CH2CO2H)2), 4.09 [4 H, s, 2 × N(CH 2CO2H)], 4.19 [8 H, s, 2 × N(CH 2 CO2H)2], 7.13 (4 H, m, CHar);
13C NMR (50 MHz, D2O): δ = 50.4 [2 × NCH2 CH2N(CH2CO2H)2], 56.5 [2 × NCH2CH2N(CH2CO2H)2], 57.3 [2 × N(CH2CO2H)], 58.5 [2 × N(CH2CO2H)2], 125.7 [2 × CHar], 128.8 [2 × CHar], 145.0 [2 × Car], 171.9 [4 × N(CH2 CO2H)2], 178.2 [2 × N(CH2 CO2H)]; MS (ES+): = 543.1 (M + H+), 565.1 (M + Na+); mp >300 °C.